Drugs / 19#iSCLife®-UT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05495711 | Aug 2022 → Jun 2023 | female infertility | Sclnow Biotechnology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 19#iSCLife-UT | “Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-UT)” NCT05495711 ↗ |
| Modality | Cell therapy | “Human Umbilical Cord Mesenchymal Stem Cells” NCT05495711 ↗ |
| Route | Other | “intrauterine injection with human umbilical cord mesenchymal stem cell (19#iSCLife®-UT)” NCT05495711 ↗ |